Results 21 to 30 of about 58,537 (229)
G4.5 Pamam Dendrimer-Risperidone: Biodistribution and Behavioral Changes in In Vivo Model [PDF]
, 2013 Dendritic polymers are considered as emerging and outstanding carriers as modern medicinal systems due to their derivatisable branched architecture and possibility to modify them in numerous ways.
Alonso, Silvia del Valle +6 more
core +2 more sources
CYP2D6 Genotype-Based Dose Recommendations for Risperidone in Asian People
Frontiers in Pharmacology, 2020 The aim of this study was to provide dose recommendations for risperidone in Asian people based on cytochrome P450 enzyme CYP2D6 genotype. First, we investigated the influence of CYP2D6 polymorphism on the pharmacokinetics of risperidone in Chinese ...
Yuanxia Cui +14 more
doaj +1 more source
Cannabis and schizophrenia [PDF]
, 2014 BACKGROUND Schizophrenia is a mental illness causing disordered beliefs, ideas and sensations. Many people with schizophrenia smoke cannabis, and it is unclear why a large proportion do so and if the effects are harmful or beneficial. It is also unclear
Gillies, Donna +6 more
core +1 more source
Atypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective study. [PDF]
, 2017 ObjectiveParkinson's disease psychosis (PDP) is a frequent complication of idiopathic Parkinson's disease (iPD) with significant impact on quality of life and association with poorer outcomes.
Bizzarri +29 more
core +2 more sources
Drug Design, Development and Therapy, 2021 David P Walling,1 Howard A Hassman,2 Lourdes Anta,3 Lourdes Ochoa,4 Ignacio Ayani,3 Javier Martínez,3 Ibon Gutierro4 1Collaborative Neuroscience Network, LLC Garden Grove, Garden Grove, CA, USA; 2Hassman Research Institute, Berlin, NJ, USA; 3Medical ...
Walling DP +6 more
doaj
Relapse in patients with schizophrenia: a comparison between risperidone and haloperidol [PDF]
Brazilian Journal of Psychiatry, 2003 OBJECTIVES: To compare rates of rehospitalization and time to relapse in risperidone vs. haloperidol-treated schizophrenic patients discharged from the hospital. METHODS: Randomized controlled trial comparing risperidone and haloperidol regarding relapse
Eduardo Pondé de Sena +4 more
doaj +1 more source
Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders [PDF]
, 2019 Objective To systematically evaluate the efficacy of treatments for tics and the risks associated with their use. Methods This project followed the methodologies outlined in the 2011 edition of the American Academy of Neurology\u27s guideline development
Cavanna, Andrea E +12 more
core +2 more sources
Neuropsychopharmacology Reports, 2021 Aim Several reports have shown that risperidone increases prolactin concentrations, while aripiprazole decreases prolactin concentrations. The frequency of abnormal prolactin concentrations in patients with schizophrenia receiving these drugs is still ...
Minami Tasaki +5 more
doaj +1 more source
Risperidone-induced maculopapular rashes in a child
Annals of Indian Psychiatry, 2023 We report the case and the literature focusing on dermatological problems as a possible side effect of risperidone. A 10-year-old boy with attention deficit hyperactivity disorder, who was maintaining well on atomoxetine, developed rashes on addition of ...
Enub Ali, Ankur Sachdeva, Shanta Passi
doaj +1 more source
Annals of General Psychiatry, 2009 Background A reporting association of risperidone with pituitary tumors has been observed. Because such tumors are highly prevalent, there may be other reasons why they were revealed in association with risperidone treatment.
Wu Jasmanda +4 more
doaj +1 more source